Originally published Wednesday, December 17, 2008 at 12:00 AM
Comments (3)
E-mail article
Print view
FTC accuses firm of drug monopoly
Antitrust enforcers accused Ovation Pharmaceuticals of cornering the U.S. market on a drug for a congenital heart defect in premature infants and asked a court to break up the company's monopoly on the medication.
Bloomberg News
WASHINGTON — Antitrust enforcers accused Ovation Pharmaceuticals of cornering the U.S. market on a drug for a congenital heart defect in premature infants and asked a court to break up the company's monopoly on the medication.
Ovation imposed a 1,300 percent price increase for the drug Indocin IV soon after it acquired the U.S. rights to NeoProfen, the only other drug used to treat the potentially fatal defect, the Federal Trade Commission (FTC) said on Tuesday. The failure of a blood vessel in the heart to close after birth is found in more than 30,000 premature infants each year in the United States, the FTC said.
The agency sued in federal court in Minnesota to force privately held Ovation to sell one of the drugs and repay to purchasers "all unlawfully obtained profits" from the drug monopoly dating to 2006.
An Ovation official said the company "strongly disputes the claims in the complaint" and "welcomes the opportunity to demonstrate in court" that the FTC's case is "without merit."
Ovation, based in Deerfield, Ill., purchased the rights to Indocin from Merck in August 2005. The FTC said Ovation then bought the rights to NeoProfen from Abbott Laboratories in January 2006.
As soon as it acquired NeoProfen, Ovation raised the $36 price it had been charging hospitals for each vial of Indocin to about $500, the FTC alleged in its complaint. Ovation set a price of $483 a vial for NeoProfen when it started selling the drug in July 2006, the FTC said.
The two drugs are the only alternative to risky surgery to treat a condition known as patent ductus arteriosus in which a blood vessel connecting two heart arteries fails to close.
Copyright © 2008 The Seattle Times Company
Landmark health bill passes House on close vote
Fort Hood shooting suspect had shown troubling signs

Mourners gather at KeyArena for slain officer's memorial
Mourners gathered at KeyArena for the memorial service of Seattle police Officer Timothy Brenton on November 6, 2009.
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
- Flags were key link to cop slaying, bombings
- Suspect shot as city mourns slain officer
- Briefs | Soccer: New Mexico suspends hair-pulling player Elizabeth Lambert
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- Huskies suffer another heartbreaking loss to UCLA
- McGinn pulling away as late ballots come in
- Using anti-shooter tactics, civilian Army police officer brought down gunman
- How an underdog named Mike McGinn took City Hall
- 3 Cascade Mountain passes close due to snow; more rain, wind expected Sunday
- Heavy snow in Cascades shuts down roads
- UCLA game thread
940 - Weapons, bomb-making materials found in suspect's apartment
334 - Troubling portrait emerges of Fort Hood suspect
293 - U.S. House passes health plan
222 - Decision day for health care in the House
201 - Bombs, guns found at home of suspect in Officer Brenton's slaying
151 - Huskies suffer another heartbreaking loss to UCLA
102 - Referendum 71 show's Washington's strategy for marriage equality is working
96 - Grading the game
89 - How an underdog named Mike McGinn took City Hall
58
- Suspect shot as city mourns slain officer
- Flags were key link to cop slaying, bombings
- 10 ways to take control of your health
- Danny Westneat | Lee the Horse Logger found slow wagon shrank tumor
- The birth of 'Grunge,' in photos by Michael Lavine
- 10 investing missteps to avoid
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- Guest columnist | Cut the South Carolina jokes, Seattle. Get ready to compete
- How do innovators think?
- Consortium on verge of owning Eastside railway land






